Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Boston Children's Hospital
Massachusetts General Hospital
Institute of Hematology & Blood Diseases Hospital, China
Cullgen (Shanghai),Inc
Medical University of Gdansk
Ohio State University Comprehensive Cancer Center
Peter MacCallum Cancer Centre, Australia
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Affiliated Hospital of Qinghai University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
Medical College of Wisconsin
Tampere University Hospital
European Institute of Oncology
Universitaire Ziekenhuizen KU Leuven
Hospital Universitari Vall d'Hebron Research Institute
University of Nebraska
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Alabama at Birmingham
Baylor College of Medicine
Malaghan Institute of Medical Research
Brown University
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
PrECOG, LLC.
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Indonesia University
Boston Children's Hospital
University College, London
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Arizona
Dana-Farber Cancer Institute
Columbia University